Resolution Therapeutics at Cell 2026
Nov 12–13, 2026 London, UK ~800 attendees Website
Resolution Therapeutics takes part in 5 sessions at Cell 2026 in London, its home city. Its sessions cover manufacturing and quality strategy matched to each clinical phase, the regulatory lifecycle of advanced therapies and how far AI is ready for safe use. It also covers the hurdles in developing a macrophage-based regenerative therapy for fibro-inflammatory disease.
| Organization | Cell 2026 Attendance |
|---|---|
Resolution Therapeutics London, UK | |
Develops regenerative macrophage therapies for inflammatory and fibrotic diseases, led by a programme in end-stage liver disease. | Talk Thu Nov 12 10:15am–10:40am Building For The Future: Phase-Appropriate CMC Strategies Manufacturing and CMC Panel Thu Nov 12 2:40pm–3:05pm The AI Reality Check: What’s Ready Now, What Isn’t, And How Do We Validate It Safely? Digital biomanufacturing and AI Panel Fri Nov 13 4:40pm–5:05pm Panel Fri Nov 13 4:40pm–5:05pm Navigating The Regulatory Lifecycle Of Advanced Therapies: From Platform Approval To Manufacturing & Post-Market Evidence Cell and gene therapyManufacturing and CMC Talk Fri Nov 13 5:05pm–5:30pm |
Instantly find 20 buyers from Resolution Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction